<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Matrix metalloproteinases (MMPs) play an important role in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development and <z:hpo ids='HP_0000718'>aggression</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>MMP-9 polymorphisms may affect MMPs expression and contribute to interindividual differences in susceptibility to a wide spectrum of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to investigate the association of MMP-9 P574R and R668Q polymorphisms with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>); and to explore the relationship among the polymorphisms and clinicopathologic parameters, serum <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> markers and <z:chebi fb="23" ids="18059">lipids</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The genotypes were determined by polymerase chain reaction-restriction fragment lengthy polymorphism (PCR-RFLP) </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> markers were measured with the Electro ChemiL uminescence method </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="23" ids="18059">Lipids</z:chebi> levels were analyzed using an automatic biochemistry analyzer </plain></SENT>
<SENT sid="6" pm="."><plain>The both polymorphisms were not associated with the risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk </plain></SENT>
<SENT sid="7" pm="."><plain>The clinicopathologic parameters, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> markers were not associated with MMP-9 polymorphisms </plain></SENT>
<SENT sid="8" pm="."><plain>Total cholesterol (TC) and <z:chebi fb="1" ids="47774">low-density lipoprotein cholesterol</z:chebi> (<z:chebi fb="0" ids="47774">LDL-C</z:chebi>) were significantly higher in patients with P574R PP genotype compared with patients with P574R PR combined RR genotypes (P = 0.043 and P = 0.038 respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>Our data suggested that MMP-9 P574R and R668Q were not associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk, but P574R affected serum <z:chebi fb="0" ids="47774">LDL-C</z:chebi> and TC levels in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
</text></document>